Effects of denosumab on bone mineral density and bone turnover markers in rheumatoid arthritis patients switching from bisphosphonates

BACKGROUND: To compare the efficacy of 12-month denosumab treatment on bone mineral density (BMD) and bone turnover markers (BTMs) between treatment-naïve osteoporosis patients with rheumatoid arthritis (RA) and those with previous bisphosphonate (BP) therapy. METHODS: A total of 36 RA patients with...

Descripción completa

Detalles Bibliográficos
Autores principales: Kaneko, Tetsuya, Okamura, Koichi, Yonemoto, Yukio, Okura, Chisa, Suto, Takahito, Tachibana, Masahiro, Sakane, Hideo, Inoue, Makoto, Chikuda, Hirotaka
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2019
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6820644/
https://www.ncbi.nlm.nih.gov/pubmed/31664591
http://dx.doi.org/10.1186/s40634-019-0211-7

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6820644/
https://www.ncbi.nlm.nih.gov/pubmed/31664591
http://dx.doi.org/10.1186/s40634-019-0211-7

Ejemplares similares